IP Library Granted Patent US 8,546,110
Granted Patent B2
US 8,546,110 · App. 12/241,353 · Granted Oct 1, 2013

Method for detecting the presence of a nucleic acid in a sample

Inventors: Kelly G. Ammann (Longmont, CO); Ralph E. Burns (Boulder, CO); Ernest V. Hansberry (Evergreen, CO); Glenn A. Horner (Boulder, CO); Cheryl A. Jakub (Golden, CO); John E. Kling (San Diego, CA); Donald J. Nieglos (Superior, CO); Robert E. Schneider (Erie, CO); Robert J. Smith (Louisville, CO)
Assignee: Gen-Probe Incorporated
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,546,110
App. No.
12/241,353
Granted
Oct 1, 2013
Kind
B2
Abstract

An automated method for preparing and amplifying a sequence contained in a nucleic acid present in a sample, the nucleic acid being prepared in a receptacle that is part of a unit that includes a plurality of receptacles and holds a removable contact-limiting element for aspirating a fluid component of the sample from the receptacle.

Claims (47)

1. A method for detecting the presence of a nucleic acid in a sample, the method comprising performing in an analyzer the automated steps of:

(a) combining, in a receptacle, a sample containing a nucleic acid and a solid support comprising a magnetically-responsive particle, the solid support forming a complex with the nucleic acid, wherein the complex is suspended in a fluid component of the sample, the receptacle being part of a unit comprising a plurality of integrally formed receptacles, and the unit holding a removable contamination-limiting element configured to permit passage of the fluid component of the sample therethrough;

(b) subjecting the contents of the receptacle to a magnetic field, thereby isolating the nucleic acid within the receptacle;

(c) mounting the contamination-limiting element onto a fluid aspirator;

(d) purifying the nucleic acid isolated in step (b) by contacting the fluid component of the sample with the contamination-limiting element and aspirating at least a portion of the fluid component with the fluid aspirator while the complex remains subjected to the magnetic field;

(e) forming a reaction mixture comprising the purified nucleic acid of step (d) and all reagents required to perform a nucleic acid amplification;

(f) performing a nucleic acid amplification with the reaction mixture formed in step (e), the nucleic acid amplification resulting in the enzymatic synthesis of amplification products, each of the amplification products comprising (i) a target sequence contained in the nucleic acid or (ii) the complement of the target sequence;

(g) selectively hybridizing a probe having a label to the target sequence or its complement of an amplification product that is one of the amplification products synthesized in step (f), thereby forming a hybrid in a mixture that comprises the probe and the amplification product; and

(h) in the mixture, detecting the formation of the hybrid, wherein the formation of the hybrid in the mixture is an indication of the presence of the nucleic acid in the sample.

2. The method of claim 1 , wherein each of the receptacles comprises a cylindrical tube.

3. The method of claim 1 , further comprising performing in the analyzer an automated step of sensing the level of the fluid component in step (d), wherein the contamination-limiting element is mounted on an aspirator tube of the fluid aspirator, and wherein the aspirator tube and the contamination-limiting element constitute a portion of a capacitor for performing capacitive fluid level sensing.

4. The method of claim 1 , wherein the contamination-limiting element is one of a plurality of contamination-limiting elements held by the unit, wherein each of the contamination-limiting elements is configured to permit passage of a fluid component of a sample therethrough, and wherein each of the contamination-limiting elements is operationally associated with one of the receptacles of the unit.

5. The method of claim 1 , wherein the contamination-limiting element is held in a frictional fit by the unit when the contamination-limiting element is mounted onto the fluid aspirator in step (c).

6. The method of claim 1 , wherein the complex further comprises a capture probe, and wherein the capture probe is immobilized on the solid support and hybridized to the nucleic acid.

7. The method of claim 1 , further comprising performing in the analyzer an automated step of washing the solid support one or more times with a wash buffer after step (d) and prior to step (e).

8. The method of claim 1 , wherein each of the amplification products consists of a nucleic acid sequence having the target sequence or its complement.

9. The method of claim 1 , wherein the amplification products include nucleic acid sequences having a sequence that is the same as the target sequence and nucleic acid sequences having a sequence that is the complement of the target sequence.

10. The method of claim 1 , wherein step (f) is carried out in a temperature-controlled incubator maintained at a substantially uniform temperature.

11. The method of claim 1 , wherein step (f) is performed in a temperature-controlled chamber of a first incubator, and wherein step (g) is performed in a temperature-controlled chamber of a second incubator, the first and second incubators being in a spaced-apart relationship.

12. The method of claim 1 , wherein the hybrid is in solution.

13. The method of claim 1 , wherein the steps of the method are performed within a housing of the analyzer.

14. The method of claim 13 , wherein the steps of the method are performed at multiple locations of a processing deck contained within the housing.

15. The method of claim 13 , wherein the housing remains closed during the method.

16. A method for detecting the presence of a nucleic acid in a sample, the method comprising performing in an analyzer the automated steps of:

(a) combining, in a receptacle, a sample containing a nucleic acid and a solid support comprising a magnetically-responsive particle, the solid support forming a complex with the nucleic acid, wherein the complex is suspended in a fluid component of the sample, the receptacle being part of a unit comprising a plurality of integrally formed receptacles, and the unit holding a removable tiplet comprising an axially extending through-hole for drawing fluids therethrough;

(b) subjecting the contents of the receptacle to a magnetic field, thereby isolating the nucleic acid within the receptacle;

(c) mounting the tiplet onto a fluid aspirator;

(d) purifying the nucleic acid isolated in step (b) by contacting the fluid component of the sample with the tiplet and aspirating at least a portion of the fluid component with the fluid aspirator while the complex remains subjected to the magnetic field;

(e) forming a reaction mixture comprising the purified nucleic acid of step (d) and all reagents required to perform a nucleic acid amplification;

(f) performing a nucleic acid amplification with the reaction mixture formed in step (e), the nucleic acid amplification resulting in the enzymatic synthesis of amplification products, each of the amplification products comprising (i) a target sequence contained in the nucleic acid or (ii) the complement of the target sequence;

(g) selectively hybridizing a probe having a label to the target sequence or its complement of an amplification product that is one of the amplification products synthesized in step (f), thereby forming a hybrid in a mixture that comprises the probe and the amplification product; and

in the mixture, detecting the formation of the hybrid, wherein the formation of the hubrid in the mixture is an indication of the presence of the nucleic acid in the sample.

17. The method of claim 16 , wherein each of the receptacles comprises a cylindrical tube.

18. The method of claim 16 , wherein the tiplet is electrically conductive.

19. The method of claim 18 , further comprising performing in the analyzer an automated step of sensing the level of the fluid component in step (d), wherein the tiplet is mounted on an aspirator tube of the fluid aspirator, and wherein the aspirator tube and the tiplet constitute a portion of a capacitor for performing capacitive fluid level sensing.

20. The method of claim 16 , wherein the tiplet is one of a plurality of tiplets held by the unit, wherein each of the tiplets is configured to permit passage of a fluid component of a sample therethrough, and wherein each of the tiplets is operationally associated with one of the receptacles of the unit.

21. The method of claim 16 , wherein the tiplet is held in a frictional fit by the unit when the tiplet is mounted onto the fluid aspirator in step (c).

22. The method of claim 16 , wherein the complex further comprises a capture probe, and wherein the capture probe is immobilized on the solid support and hybridized to the nucleic acid.

23. The method of claim 16 , further comprising performing in the analyzer an automated step of washing the solid support one or more times with a wash buffer after step (d) and prior to step (e).

24. The method of claim 16 , wherein each of the amplification products consists of a nucleic acid sequence having the target sequence or its complement.

25. The method of claim 16 , wherein the amplification products include nucleic acid sequences having a sequence that is the same as the target sequence and nucleic acid sequences having a sequence that is the complement of the target sequence.

26. The method of claim 16 , wherein step (f) is carried out in a temperature-controlled incubator maintained at a substantially uniform temperature.

27. The method of claim 16 , wherein step (f) is performed in a temperature-controlled chamber of a first incubator, and wherein step (g) is performed in a temperature-controlled chamber of a second incubator, the first and second incubators being in a spaced-apart relationship.

28. The method of claim 16 , wherein the hybrid is in solution.

29. The method of claim 16 , wherein the steps of the method are performed within a housing of the analyzer.

30. The method of claim 29 , wherein the steps of the method are performed at multiple locations of a processing deck contained within the housing.

31. The method of claim 29 , wherein the housing remains closed during the method.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075566/0039 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 028810 FRAME: 0745. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 035820 FRAME: 0239. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST RELEASE. Recorded Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 044727/0529 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL/FRAME 028810/0745 Recorded Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035820/0239 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 21, 2013
From: AMMANN, KELLY G.; BURNS, RALPH E.; HANSBERRY, ERNEST V.; HORNER, GLENN A.; JAKUB, CHERYL A.; KLING, JOHN E.; NIEGLOS, DONALD J.; SCHNEIDER, ROBERT E.; SMITH, ROBERT J.
To: GEN-PROBE INCORPORATED
Reel/Frame 029851/0190 →
SECURITY AGREEMENT Recorded Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 27, 2008
From: AMMANN, KELLY G.; BURNS, RALPH E.; HANSBERRY, ERNEST V.; HORNER, GLENN A.; JAKUB, CHERYL A.; KLING, JOHN E.; NIEGLOS, DONALD J.; SCHNEIDER, ROBERT E.; SMITH, ROBERT J.
To: GEN-PROBE INCORPORATED
Reel/Frame 021739/0321 →
Continuity (6)
Continuation 11873818 · Oct 17, 2007
Continuation 10946557 · Sep 22, 2004
Continuation 09985064 · Nov 1, 2001
Continuation 09303030 · Apr 30, 1999
Provisional Application 60083927 · May 1, 1998
Related Publication 20090029352A1 · Jan 29, 2009